Canadian business and philanthropic leaders call on their peers to #ShareTheHealth and donate to UNICEF’s COVID-19 Global Vaccination Efforts
27 mai 2021 08h30 HE
|
UNICEF Canada
Toronto, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- Today, 16 senior leaders from top Canadian companies and foundations, including Teck Resources Limited and Fairmount Foundation, released an Open...
Global Smart Commodity Group Partners with Advanced Hemp Processing
28 avr. 2021 14h00 HE
|
Global Smart Commodity Group
CHICAGO, April 28, 2021 (GLOBE NEWSWIRE) -- Global Smart Commodity Group (GSCG) is thrilled to be working with Advanced Hemp Processing (AHP) who is now GMP certified to Annex 2 WHO. With this...
Meningitis Canada Urges Policy Makers to Help Defeat Meningitis
23 avr. 2021 09h00 HE
|
Meningitis Foundation
WATERLOO, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- This World Meningitis Day (April 24th), Meningitis Foundation Canada (MFC) is raising awareness of this ‘indiscriminate killer disease’ and...
BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator
15 nov. 2020 19h35 HE
|
BioAegis Therapeutics
No drug-related safety signals identified by the independent Data and Safety Monitoring Board.MORRISTOWN, N.J., Nov. 15, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage,...
WHO Leader to Address CONV2X 2020
05 nov. 2020 16h10 HE
|
Partners in Digital Health
STAMFORD, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- World Health Organization (WHO) Director - General Dr. Tedros Adhanom Ghebreyesus will address the 4th Annual ConVerge2Xcelerate (#CONV2X) 2020...
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
26 oct. 2020 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...
BioAegis Therapeutics Announces Study Indicating Gelsolin Treatment Improves Survival and Reduces Lung Injury in Antibiotic Resistant Pneumonia
03 sept. 2020 21h42 HE
|
BioAegis Therapeutics
MORRISTOWN, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through...
Independent Studies Confirm Low Levels of Immune System Protein, Gelsolin, Associated with COVID-19 Severity
17 août 2020 10h57 HE
|
BioAegis Therapeutics
BioAegis Conducting COVID-19 Clinical Trial of Gelsolin Therapeutic MORRISTOWN, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing...
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path to FDA EUA, and Commercialization
20 avr. 2020 09h00 HE
|
PharmaCyte Biotech
NEW YORK, NY, April 20, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) recently entered into a licensing agreement with Hai Kang Life Corporation (Hai Kang), where Hai Kang granted to...
Canadian charity makes COVID-19 information accessible in local dialects
13 avr. 2020 16h00 HE
|
LetsStopAIDS
TORONTO, April 13, 2020 (GLOBE NEWSWIRE) -- LetsStopAIDS, Canada’s youth-HIV charity, has created a platform to ensure that information about COVID-19 is available to vulnerable populations where...